logo
AAT Bioquest

Sodium channel protein type I alpha subunit Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
N-[[5-[1-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamideIC5021000.0 [1], 100000.0 [2]
N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamideIC502550.0 [1], 8540.0 [2], 15300.0 [3]
6-(4-(Trifluoromethoxy)phenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridineIC50400.0 [1], 10000.0 [2]
2,2-Diphenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]acetamideIC5020.0 [1], 32.0 [2]
2-[(3-Methyl-1,2,4-oxadiazol-5-yl)methyl]-6-[4-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[4,3-a]pyridin-3-oneIC504800.0 [1], 10000.0 [2]
TetrodotoxinIC5030.0 [1]
Mexiletine hydrochlorideIC5011000.0 [1]
SenicapocIC501000.0 [1]
CID 46840946IC50677.0 [1]
EleclazineIC503400.0 [1]
6-Amino-N-methyl-5-(2,3,5-trichlorophenyl)picolinamideIC5013000.0 [1]
1-[2-Methoxy-4-[3-(trifluoromethyl)phenyl]phenyl]-2-oxo-N-pyrimidin-2-ylquinoline-6-sulfonamideIC5042500.0 [1]
CID 91666633IC5045.0 [1]
4-[4-Chloro-2-[2-(1-ethylazetidin-3-yl)pyrazol-3-yl]phenoxy]-3-cyano-N-(1,3-thiazol-4-yl)benzenesulfonamideIC5010000.0 [1]
5-Chloro-2-fluoro-4-[2-pyridazin-4-yl-4-(trifluoromethyl)phenoxy]-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamideIC508750.0 [1]
2-(4-(4-(Trifluoromethoxy)phenyl)-1H-imidazol-2-yl)propan-2-amineIC5011000.0 [1]
4-[2-(2-Amino-3H-benzimidazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamideIC506380.0 [1]
4-[2-(3-Amino-1,2-benzoxazol-5-yl)-4-chlorophenoxy]-2,5-difluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamideIC503080.0 [1]
4-[4-Chloro-2-(2-methylpyrazol-3-yl)phenoxy]-3-fluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamideIC50216.0 [1]
4-[4-Chloro-2-(2-methylpyrazol-3-yl)phenoxy]-3-cyano-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamideIC503000.0 [1]
4-[2-Methoxy-4-(trifluoromethyl)phenyl]-N-(1,3-thiazol-2-yl)quinazoline-7-sulfonamideIC507300.0 [1]
N-[6-Cyclopropyl-7-[(3,5-dichlorophenoxy)methyl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methanesulfonamideIC50112.0 [1]
3-Cyano-4-[2-[2-[(2-piperidin-4-ylethylamino)methyl]pyridin-4-yl]-4-[3-(trifluoromethyl)phenyl]phenoxy]-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamideIC50309.0 [1]
1-[5-Fluoro-2-methoxy-4-[3-(trifluoromethyl)phenyl]phenyl]-N-(1,2-oxazol-3-yl)isoquinoline-6-sulfonamideIC5017000.0 [1]
2-[1-[2-Hydroxy-3-[3-(trifluoromethyl)phenoxy]propyl]piperidin-4-yl]-3H-isoindol-1-oneIC501200.0 [1]
2-[1-[2-Hydroxy-3-[4-(trifluoromethyl)phenoxy]propyl]piperidin-4-yl]-3H-isoindol-1-oneIC501800.0 [1]
2-[1-[2-Hydroxy-3-[2-methoxy-4-(trifluoromethyl)phenoxy]propyl]piperidin-4-yl]-3H-isoindol-1-oneIC50910.0 [1]
2-[1-[2-Hydroxy-3-[[4-(trifluoromethyl)phenyl]methoxy]propyl]piperidin-4-yl]-3H-isoindol-1-oneIC503000.0 [1]
N-[1-[2-Hydroxy-3-[4-(trifluoromethyl)phenoxy]propyl]piperidin-4-yl]benzamideIC50800.0 [1]
1-[2-Hydroxy-3-[4-(trifluoromethyl)phenoxy]propyl]-N-phenylpiperidine-4-carboxamideIC503100.0 [1]
1-[2-Hydroxy-3-[[2-methoxy-4-(trifluoromethyl)phenyl]methoxy]propyl]-N-phenylpiperidine-4-carboxamideIC503300.0 [1]
8-[4-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperazin-1-yl]-4H-1,4-benzoxazin-3-oneIC5033000.0 [1]
8-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-4H-1,4-benzoxazin-3-oneIC504400.0 [1]
5-[4-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-oneIC5021000.0 [1]
5-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-3,4-dihydro-1H-quinolin-2-oneIC507100.0 [1]
7-[4-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperazin-1-yl]-3H-1,3-benzoxazol-2-oneIC5033000.0 [1]
4-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-1,4-benzoxazin-3-oneIC504800.0 [1]
3-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-1,3-benzoxazol-2-oneIC505400.0 [1]
1-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-3H-indol-2-oneIC5026000.0 [1]
2-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-3H-isoindol-1-oneIC503300.0 [1]
N-[1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]benzamideIC503200.0 [1]
1-[3-(2-Benzoylphenoxy)-2-hydroxypropyl]-N-phenylpiperidine-4-carboxamideIC504300.0 [1]
2-[1-[3-(3-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-3H-isoindol-1-oneIC50920.0 [1]
2-[1-[3-(4-Benzoylphenoxy)-2-hydroxypropyl]piperidin-4-yl]-3H-isoindol-1-oneIC50670.0 [1]
2-[1-(2-Hydroxy-3-phenoxypropyl)piperidin-4-yl]-3H-isoindol-1-oneIC508000.0 [1]
2-[1-[2-Hydroxy-3-(2-methoxyphenoxy)propyl]piperidin-4-yl]-3H-isoindol-1-oneIC5019000.0 [1]
2-[1-[2-Hydroxy-3-(3-methoxyphenoxy)propyl]piperidin-4-yl]-3H-isoindol-1-oneIC503000.0 [1]
2-[1-[2-Hydroxy-3-(4-methoxyphenoxy)propyl]piperidin-4-yl]-3H-isoindol-1-oneIC502700.0 [1]
2-[1-[2-Hydroxy-3-[2-(trifluoromethyl)phenoxy]propyl]piperidin-4-yl]-3H-isoindol-1-oneIC504500.0 [1]
1H-Pyrazole-5-carboxamide, N-(6-amino-5-(2-chloro-5-methoxyphenyl)-2-pyridinyl)-1-methyl-IC5037000.0 [1]
N-[7-(1-Adamantylmethoxy)-6-cyclopropyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methanesulfonamideIC5053.0 [1]
2-[1-[2-Hydroxy-3-[[2-methoxy-4-(trifluoromethyl)phenyl]methoxy]propyl]piperidin-4-yl]-3H-isoindol-1-oneIC501500.0 [1]
4-[[3-Chloro-4-(trifluoromethoxy)phenyl]methoxy]-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamideIC50455.0 [1]
N-[[3-Chloro-4-(trifluoromethoxy)phenyl]methyl]-3-fluoro-4-(1,2,4-thiadiazol-5-ylsulfamoyl)benzamideIC5012.0 [1]
N-[[3-Chloro-4-(trifluoromethoxy)phenyl]methyl]-3-fluoro-4-(1,3-thiazol-2-ylsulfamoyl)benzamideIC5020.0 [1]
3-[[5-[4-(Trifluoromethoxy)phenyl]-1H-imidazol-2-yl]methyl]oxetan-3-amineIC5043000.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Sodium channel protein type I alpha subunit Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Dec2024https://www.aatbio.com/data-sets/sodium-channel-protein-type-i-alpha-subunit-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024December 21). Quest Database™ Sodium channel protein type I alpha subunit Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/sodium-channel-protein-type-i-alpha-subunit-inhibitors-ic50-ki.
BibTeXEndNoteRefMan